154 related articles for article (PubMed ID: 35016597)
1. Synthesis of New Pyrazole Hybrids as Potential Anticancer Agents with Xanthine Oxidase Inhibitory Activity.
Alsayari A; Asiri YI; Bin Muhsinah A; Hassan MZ
Anticancer Agents Med Chem; 2022; 22(12):2303-2309. PubMed ID: 35016597
[TBL] [Abstract][Full Text] [Related]
2. Anticolon Cancer Properties of Pyrazole Derivatives Acting through Xanthine Oxidase Inhibition.
Alsayari A; Asiri YI; Muhsinah AB; Hassan MZ
J Oncol; 2021; 2021():5691982. PubMed ID: 34326873
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
[TBL] [Abstract][Full Text] [Related]
5. Novel bis(pyrazole-benzofuran) hybrids possessing piperazine linker: Synthesis of potent bacterial biofilm and MurB inhibitors.
Mekky AEM; Sanad SMH
Bioorg Chem; 2020 Sep; 102():104094. PubMed ID: 32711085
[TBL] [Abstract][Full Text] [Related]
6. Annulated pyrazole derivatives as a novel class of urokinase (uPA) inhibitors: Green synthesis, anticancer activity, DNA-damage evaluation, and molecular modelling study.
Farag PS; AboulMagd AM; Hemdan MM; Hassaballah AI
Bioorg Chem; 2023 Jan; 130():106231. PubMed ID: 36335649
[TBL] [Abstract][Full Text] [Related]
7. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
10. Polymer microspheres modified with pyrazole derivatives as potential agents in anticancer therapy - Preliminary studies.
Podkościelna B; Klimek K; Karczmarzyk Z; Wysocki W; Brodacka M; Serafin K; Kozyra P; Kowalczuk D; Ginalska G; Pitucha M
Bioorg Chem; 2022 Jun; 123():105765. PubMed ID: 35427940
[TBL] [Abstract][Full Text] [Related]
11. Novel Pyrazole-Based Benzofuran Derivatives as Anticancer Agents: Synthesis, Biological Evaluation, and Molecular Docking Investigations.
Ameziane El Hassani I; Altay A; Karrouchi K; Yeniçeri E; Türkmenoğlu B; Assila H; Boukharssa Y; Ramli Y; Ansar M
Chem Biodivers; 2023 Nov; 20(11):e202301145. PubMed ID: 37781955
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity Evaluation of Pyrazole-1,2,4-triazole Hybrids: A Computer-aided Docking Studies.
Mallisetty NM; Ganipisetti H; Majhi D; Sirisilla R; Kumar Putta VN
Curr Drug Discov Technol; 2023; 20(2):e251122211263. PubMed ID: 36437730
[TBL] [Abstract][Full Text] [Related]
13. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Novel Pyrazole Derivatives as Promising DNA-Binding Agents and Evaluation of Antitumor and Antitopoisomerases I/II Activities.
Feng J; Qi H; Sun X; Feng S; Liu Z; Song Y; Qiao X
Chem Pharm Bull (Tokyo); 2018 Nov; 66(11):1065-1071. PubMed ID: 30197406
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R
Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509
[TBL] [Abstract][Full Text] [Related]
16. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
17. EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules.
Abou-Zied HA; Youssif BGM; Mohamed MFA; Hayallah AM; Abdel-Aziz M
Bioorg Chem; 2019 Aug; 89():102997. PubMed ID: 31136902
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
[TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
Yang M; Liu H; Zhang Y; Wang X; Xu Z
Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
